Health CLINUVEL Launches CYACÊLLE, Next Generation Solar Care James Pereira Mar 1, 2023 <!-- Name:DistributionId Value:8778935 --> <!--… Read More...
Health CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals James Pereira Feb 2, 2023 <!-- Name:DistributionId Value:8741323 --> <!--… Read More...
Health CLINUVEL Trial Results Show Drug Reduces DNA Damage James Pereira Jan 16, 2023 MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair… Read More...
Health CLINUVEL progresses vitiligo treatment program James Pereira May 10, 2022 MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder vitiligo… Read More...
Health Positive final results in stroke James Pereira May 4, 2022 ASX: XETRA-DAX: Level 1 ADR:CUV UR9 CLVLY EXECUTIVE SUMMARY afamelanotide evaluated as safe in mild to moderate… Read More...
Health CLINUVEL Expands Pharmaceutical Portfolio James Pereira Nov 8, 2021 MELBOURNE, Australia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CLINUVEL has expanded its pharmaceutical development… Read More...